Egfr Activating Mutation clinical trials

Explore recruiting egfr activating mutation clinical trials.

Recruiting egfr activating mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Egfr Activating Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HERTHENA–Lung02: A Phase 3, Randomized, Open-label Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) After Failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy

Italy, Netherlands, Poland, Austria, France, Spain +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Egfr Activating Mutation trials by city

Egfr Activating Mutation in Toronto Egfr Activating Mutation in Vancouver Egfr Activating Mutation in Montreal Egfr Activating Mutation in Calgary Egfr Activating Mutation in Edmonton Egfr Activating Mutation in Ottawa Egfr Activating Mutation in Winnipeg Egfr Activating Mutation in Quebec City Egfr Activating Mutation in Hamilton Egfr Activating Mutation in Kitchener Egfr Activating Mutation in London Egfr Activating Mutation in Halifax Egfr Activating Mutation in New York Egfr Activating Mutation in Los Angeles Egfr Activating Mutation in Chicago Egfr Activating Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease